科兴制药引进产品甲苯磺酸索拉非尼获埃及药品管理局（EDA）批准上市

Group 1 - The core point of the article is that the company, Sinovac Biotech, has received approval from the Egyptian Drug Authority (EDA) for its product, Sorafenib Tosylate Tablets, to be marketed in Egypt [1] - Sorafenib is a well-known targeted therapy drug that has been widely used for the treatment of various tumors, including liver cancer and kidney cancer, since its original approval by the FDA in December 2005 [1]